Emmanuelle Nicolas-Virelizier

Emmanuelle Nicolas-Virelizier

UNVERIFIED PROFILE

Are you Emmanuelle Nicolas-Virelizier?   Register this Author

Register author
Emmanuelle Nicolas-Virelizier

Emmanuelle Nicolas-Virelizier

Publications by authors named "Emmanuelle Nicolas-Virelizier"

Are you Emmanuelle Nicolas-Virelizier?   Register this Author

25Publications

862Reads

25Profile Views

Utility of post-therapy brain surveillance imaging in the detection of primary central nervous system lymphoma relapse.

Eur J Cancer 2017 02 22;72:12-19. Epub 2016 Dec 22.

Centre Léon Bérard, Department of Hematology, Université Claude Bernard Lyon 1, Lyon, France; Department of Hematology, Centre Hospitalier Lyon Sud, Université Claude Bernard Lyon 1, Pierre-Bénite, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2016.10.036DOI Listing
February 2017

High-Dose Chemotherapy for Adult-Type Ovarian Granulosa Cell Tumors: A Retrospective Study of the European Society for Blood and Marrow Transplantation.

Int J Gynecol Cancer 2017 02;27(2):248-251

*Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori IRCCS, Meldola, Italy; †Centre Leon Berard, Lyon; and ‡EBMT Paris Office, Paris, France; §Universitatsklinikum Frankfurt, Frankfurt, Germany; ∥Hopital Tenon, Paris, France; ¶University Hospital Gasthuisberg, Leuven, Belgium; and #Hematology Unit, Ravenna Hospital, Ravenna; and **Ospedale di Busto Arsizio, Varese, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/IGC.0000000000000882DOI Listing
February 2017

[Management of side effects of targeted therapies in renal cancer: stomatological side effects (mucositis, epistaxis)].

Bull Cancer 2011 ;98(3 Suppl):S117-26

CHU HEGP, service d'oncologie médicale, 20, rue Leblanc, 75908 Paris Cedex 15, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1684/bdc.2011.1439DOI Listing
March 2015

Utility of routine post-therapy surveillance imaging in diffuse large B-cell lymphoma.

J Clin Oncol 2014 Nov 29;32(31):3506-12. Epub 2014 Sep 29.

Carrie A. Thompson, Matthew J. Maurer, James R. Cerhan, Stephen M. Ansell, David J. Inwards, Patrick B. Johnston, William R. Macon, Ivana N. Micallef, Grzegorz S. Nowakowski, Luis F. Porrata, Thomas E. Witzig, Thomas M. Habermann, Mayo Clinic, Rochester, MN; Herve Ghesquieres, Pierre Biron, Catherine Chassagne-Clément, Thérèse Gargi, Emmanuelle Nicolas-Virelizier, Marie Peix, Catherine Sebban, Centre Leon Berard, University of Lyon, Lyon, France; George J. Weiner and Brian K. Link, University of Iowa, Iowa City, IA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.55.7561DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4209102PMC
November 2014

Event-free survival at 24 months is a robust end point for disease-related outcome in diffuse large B-cell lymphoma treated with immunochemotherapy.

J Clin Oncol 2014 Apr 18;32(10):1066-73. Epub 2014 Feb 18.

Matthew J. Maurer, Hervé Ghesquières, Thomas E. Witzig, Carrie A. Thompson, Ivana N. Micallef, William R. Macon, Paul J. Kurtin, Cristine Allmer, Susan L. Slager, Thomas M. Habermann, and James R. Cerhan, Mayo Clinic, Rochester, MN; Hervé Ghesquières and Emmanuelle Nicolas-Virelizier, Centre Léon Bérard; Hervé Ghesquières and Gilles Salles, Université Claude Bernard, Unite Mixte de Recherche (UMR), Centre National de la Recherche Scientifique 5239, Lyon; Jean-Philippe Jais, Institut National de la Santé et de la Recherche Médicale (INSERM) UMR S 872, Necker Hospital, Assistance Publique-Hopitaux de Paris; Richard Delarue, Necker Hospital; Thierry Jo Molina, Paris Descartes University, Paris Centre University Hospital, Paris; Corinne Haioun, Henri Mondor Hospital, Université Paris-Est, Créteil; Frédéric Peyrade, Centre Antoine Lacassagne, Nice; Olivier Fitoussi, Polyclinique Bordeaux-Nord, Bordeaux; Gilles Salles, Hospices Civils de Lyon, Pierre Benite; Hervé Tilly, INSERM U918, Institute for Research and Innovation in Biomedicine, Centre Henri Becquerel, Rouen, France; Nicolas Ketterer, Lausanne Hospital, Lausanne, Switzerland; and Sergei I. Syrbu and Brian K. Link, University of Iowa College of Medicine, Iowa City, IA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2013.51.5866DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3965261PMC
April 2014